Citizen Health is a technology company.
Citizen Health has raised $45.0M across 2 funding rounds.
Citizen Health has raised $45.0M in total across 2 funding rounds.
Citizen Health has raised $45.0M in total across 2 funding rounds.
Citizen Health's investors include 8VC, First Round Capital, Mathias Schilling, Headline (formerly e.ventures), Oak HC/FT, Transformation Capital, Varsha Rao.
Citizen Health is a San Francisco-based healthcare technology company founded in December 2023, building an AI-powered platform that acts as a personalized AI Advocate for patients, particularly those with rare and complex conditions.[1][2][3][5][6] The platform combines AI, community insights, and longitudinal health data—including medical records, genetic information, imaging, and patient-reported outcomes—to help users interpret records, track symptoms, learn from peers, manage appointments, and identify next steps in their care.[1][2][3][4][6] It serves rare disease patients and families, addressing the exhaustion of managing fragmented health data, with features like instant answers to queries (e.g., "When was the last seizure?") and plain-language explanations.[3][6] The company raised $30M in Series A funding in August 2025 (total funding $44M), led by 8VC with participation from Headline, Transformation Capital, Chan Zuckerberg Initiative, and others, and has collaborated with over 10 pharmaceutical partners and 100+ patient communities.[1][2][3]
Citizen Health was co-founded in 2023 by Farid Vij (CEO) and Nasha Fitter (Chief Business Officer), both driven by personal experiences in rare disease advocacy and prior work in patient empowerment.[1][2][4][5] Vij entered healthcare in 2017, co-founding Ciitizen (sometimes referenced as Citizen), a company focused on aggregating patient medical records, genetic data, and imaging—primarily for oncology and precision medicine—which was acquired by Invitae in 2021.[1][2][4] He met Fitter there in 2018, and their shared vision evolved into Citizen Health, assembling a team of AI, healthcare, privacy, and consumer tech experts.[1][2] The idea emerged from gaps in patient data infrastructure and the need for proactive tools, starting with rare diseases affecting over 400 million globally, where 95% lack treatments.[2][4][5] Early traction includes partnerships with the Chan Zuckerberg Initiative's Rare As One Project and rapid funding post-launch.[3][4]
Citizen Health rides the agentic AI wave in healthcare, transforming passive patient portals into proactive advocates amid rising genetic testing accessibility and demands for personalized medicine.[1][2][3] Timing aligns with regulatory pushes like FDA rare disease innovation and challenges from NIH funding cuts, positioning it to accelerate treatments for underserved populations.[2] Market forces favoring it include AI's maturation for healthcare privacy/compliance, explosive rare disease data needs (400M+ affected), and pharma's hunt for real-world evidence via patient-led datasets.[2][3][4] It influences the ecosystem by empowering patients to contribute research-grade data, fostering collaborations with initiatives like Chan Zuckerberg, and shifting healthcare from provider-centric to patient-led models.[1][2][4]
Citizen Health is poised to expand its AI Advocate beyond rare diseases, scaling to all complex conditions with agentic features that automate care navigation and research contributions.[1][3] Trends like multimodal AI integration, decentralized health data, and pharma-patient alliances will propel growth, especially as treatments lag for 95% of rare diseases.[2] Its influence may evolve into a core infrastructure layer for patient empowerment, potentially disrupting silos via richer datasets—building directly on its founders' proven exit to deliver the clarity patients demand in a fragmented system.[1][2][5]
Citizen Health has raised $45.0M across 2 funding rounds. Most recently, it raised $30.0M Series A in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $30.0M Series A | 8VC, First Round Capital, Mathias Schilling, Headline (formerly e.ventures), Oak HC/FT, Transformation Capital, Varsha Rao | |
| Nov 1, 2024 | $15.0M Seed | 8VC, Mathias Schilling, Transformation Capital |